Pangraf 0.25 mg Capsule is a specialized medication primarily used for the prevention of organ rejection in transplant patients. This formulation contains the active ingredient Tacrolimus, which is an immunosuppressant that helps the body accept transplanted organs by suppressing the immune response. The key composition of Pangraf 0.25 mg Capsule includes Tacrolimus, which plays a crucial role in managing the body’s immune system. By inhibiting certain immune responses, Pangraf 0.25 mg Capsule ensures that the new organ is treated as part of the body, reducing the risk of rejection. This medication falls under the therapeutic category of immunosuppressants, which are essential for patients who have undergone organ transplants such as kidney, liver, or heart transplants. The primary purpose of Pangraf 0.25 mg Capsule is to maintain the balance between preventing organ rejection and minimizing potential side effects associated with long-term immunosuppression. Patients prescribed Pangraf 0.25 mg Capsule should understand its importance in their treatment regimen and adhere to their healthcare provider's instructions for optimal results. Overall, Pangraf 0.25 mg Capsule is a vital component in post-transplant care, ensuring that patients can lead healthier lives with their new organs.
Uses & Benefits
Pangraf 0.25 mg Capsule effectively prevents organ rejection in transplant patients.
This medication is crucial for individuals who have received kidney, liver, or heart transplants.
It helps maintain the body’s immune response at a level that allows for successful organ acceptance.
Pangraf 0.25 mg Capsule reduces the risk of complications associated with organ rejection.
Patients using Pangraf 0.25 mg Capsule may experience improved overall health post-transplant.
This formulation aids in managing autoimmune conditions by suppressing excessive immune activity.
Pangraf 0.25 mg Capsule can be beneficial in treating conditions like rheumatoid arthritis and psoriasis.
It supports long-term transplant success by ensuring consistent immunosuppression.
Pangraf 0.25 mg Capsule is often used in conjunction with other medications to enhance therapeutic outcomes.
This therapy can help prevent complications related to mineral deficiencies in transplant patients.
Pangraf 0.25 mg Capsule is essential for maintaining a stable environment for transplanted organs.
Patients may find that using Pangraf 0.25 mg Capsule leads to fewer hospital visits due to rejection episodes.
The medication is designed to be taken consistently for optimal effectiveness.
Pangraf 0.25 mg Capsule contributes to better quality of life for transplant recipients.
It is also used in bone marrow transplantation to prevent graft-versus-host disease.
How Pangraf 0.25 mg Capsule works
Pangraf 0.25 mg Capsule works by suppressing the immune system to prevent organ rejection after transplantation. This immunosuppressive action is crucial for the acceptance of transplanted organs.
The active ingredient, Tacrolimus, inhibits T-cell activation and proliferation, which are essential components of the immune response.
By reducing the activity of these immune cells, Pangraf 0.25 mg Capsule helps the body accept the new organ as if it were its own.
This medication decreases the production of cytokines that promote inflammation and immune responses against foreign tissues.
Pangraf 0.25 mg Capsule also helps manage autoimmune conditions by modulating immune activity.
The formulation ensures that patients maintain a delicate balance between adequate immunosuppression and minimizing side effects.
Regular monitoring of blood levels is necessary to adjust dosages and ensure efficacy while preventing toxicity.
How to use Pangraf 0.25 mg Capsule
Pangraf 0.25 mg Capsule should be taken exactly as prescribed by a healthcare professional.
The recommended dosage typically starts at one capsule daily, but this may vary based on individual needs.
It is important to take Pangraf 0.25 mg Capsule at the same time each day to maintain consistent blood levels.
The capsule should be swallowed whole with water; do not crush or chew it.
Patients should adhere to their prescribed treatment duration, which may extend for several months or longer post-transplant.
Regular blood tests are essential to monitor drug levels and kidney function during treatment with Pangraf 0.25 mg Capsule.
Consult a healthcare provider before making any changes to dosage or frequency of use.
Special instructions may include avoiding certain foods or medications that could interact with Pangraf 0.25 mg Capsule.
Lifestyle Advice
Maintain a balanced diet rich in fruits and vegetables while taking Pangraf 0.25 mg Capsule to support overall health.
Avoid high-sugar foods that could exacerbate blood glucose levels due to potential side effects from this medication.
Stay hydrated by drinking plenty of water daily; this helps support kidney function during treatment with Pangraf 0.25 mg Capsule.
Engage in regular physical activity as advised by a healthcare provider to enhance overall well-being post-transplant.
Avoid exposure to infections by practicing good hygiene and staying away from sick individuals while on immunosuppressants like Pangraf 0.25 mg Capsule.
Schedule regular follow-up appointments with healthcare providers to monitor health status and medication effectiveness.
Avoid self-medication and consult a healthcare professional before taking any new medications or supplements while using Pangraf 0.25 mg Capsule.
Side Effects
Side Effects
Common side effects of Pangraf 0.25 mg Capsule include increased blood glucose levels and insomnia.
Patients may experience elevated potassium levels and high blood pressure while on this medication.
Gastrointestinal disorders such as nausea or diarrhea can occur with Pangraf 0.25 mg Capsule use.
Some individuals may face renal toxicity or neurotoxicity as potential side effects.
Consult a doctor if side effects persist or worsen over time while taking Pangraf 0.25 mg Capsule.
Serious side effects may include signs of infection, unexplained bruising, or bleeding; seek medical attention immediately if these occur.
Patients should be aware of potential electrolyte imbalances and fluid overload while using this medication.
Precautions and Warnings
Precautions & Warnings
Pangraf 0.25 mg Capsule should not be used by individuals with known hypersensitivity to Tacrolimus or any other components of the formulation.
Patients with liver disease should use Pangraf 0.25 mg Capsule cautiously and under strict medical supervision.
Alcohol consumption should be limited while taking this medication due to potential interactions and increased side effects.
Pregnant or breastfeeding women should consult their healthcare provider before using Pangraf 0.25 mg Capsule.
Driving or operating heavy machinery may be affected by side effects such as dizziness; caution is advised.
Regular monitoring of kidney function is necessary during treatment with Pangraf 0.25 mg Capsule.
Inform healthcare providers about all medications being taken to avoid drug interactions with Pangraf 0.25 mg Capsule.
1. What is Pangraf 0.25 mg Capsule used for?
Pangraf 0.25 mg Capsule is primarily used to prevent organ rejection in transplant patients.
2. How should I take Pangraf 0.25 mg Capsule?
Pangraf 0.25 mg Capsule should be taken as prescribed by your healthcare provider, usually once daily at the same time.
3. What are the common side effects of Pangraf 0.25 mg Capsule?
Common side effects include increased blood glucose levels, insomnia, and gastrointestinal issues.
4. Can I drink alcohol while taking Pangraf 0.25 mg Capsule?
It is advisable to limit alcohol consumption while taking Pangraf 0.25 mg Capsule due to potential interactions.
5. Is there any special monitoring required while on Pangraf 0.25 mg Capsule?
Yes, regular blood tests are necessary to monitor drug levels and kidney function during treatment.
6. Who should avoid using Pangraf 0.25 mg Capsule?
Individuals with known hypersensitivity to Tacrolimus or those with severe liver disease should avoid using this medication.
7. How should I store Pangraf 0.25 mg Capsule?
Store Pangraf 0.25 mg Capsule at room temperature away from moisture and heat.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
SKU
153621
Country of Manufacture
India
Manufacturer Address
Mankind Pharma Ltd
Return/Buy Back policy
Non-returnable
Prescription Required
Yes
Storage
Please refer to the product label for storage information.
Seller
Kogland Commerce Pvt Ltd (TN)
Pangraf 0.25 mg Capsule is a specialized medication primarily used for the prevention of organ rejection in transplant patients. This formulation contains the active ingredient Tacrolimus, which is an immunosuppressant that helps the body accept transplanted organs by suppressing the immune response. The key composition of Pangraf 0.25 mg Capsule includes Tacrolimus, which plays a crucial role in managing the body’s immune system. By inhibiting certain immune responses, Pangraf 0.25 mg Capsule ensures that the new organ is treated as part of the body, reducing the risk of rejection. This medication falls under the therapeutic category of immunosuppressants, which are essential for patients who have undergone organ transplants such as kidney, liver, or heart transplants. The primary purpose of Pangraf 0.25 mg Capsule is to maintain the balance between preventing organ rejection and minimizing potential side effects associated with long-term immunosuppression. Patients prescribed Pangraf 0.25 mg Capsule should understand its importance in their treatment regimen and adhere to their healthcare provider's instructions for optimal results. Overall, Pangraf 0.25 mg Capsule is a vital component in post-transplant care, ensuring that patients can lead healthier lives with their new organs.
Uses & Benefits
Pangraf 0.25 mg Capsule effectively prevents organ rejection in transplant patients.
This medication is crucial for individuals who have received kidney, liver, or heart transplants.
It helps maintain the body’s immune response at a level that allows for successful organ acceptance.
Pangraf 0.25 mg Capsule reduces the risk of complications associated with organ rejection.
Patients using Pangraf 0.25 mg Capsule may experience improved overall health post-transplant.
This formulation aids in managing autoimmune conditions by suppressing excessive immune activity.
Pangraf 0.25 mg Capsule can be beneficial in treating conditions like rheumatoid arthritis and psoriasis.
It supports long-term transplant success by ensuring consistent immunosuppression.
Pangraf 0.25 mg Capsule is often used in conjunction with other medications to enhance therapeutic outcomes.
This therapy can help prevent complications related to mineral deficiencies in transplant patients.
Pangraf 0.25 mg Capsule is essential for maintaining a stable environment for transplanted organs.
Patients may find that using Pangraf 0.25 mg Capsule leads to fewer hospital visits due to rejection episodes.
The medication is designed to be taken consistently for optimal effectiveness.
Pangraf 0.25 mg Capsule contributes to better quality of life for transplant recipients.
It is also used in bone marrow transplantation to prevent graft-versus-host disease.
How Pangraf 0.25 mg Capsule works
Pangraf 0.25 mg Capsule works by suppressing the immune system to prevent organ rejection after transplantation. This immunosuppressive action is crucial for the acceptance of transplanted organs.
The active ingredient, Tacrolimus, inhibits T-cell activation and proliferation, which are essential components of the immune response.
By reducing the activity of these immune cells, Pangraf 0.25 mg Capsule helps the body accept the new organ as if it were its own.
This medication decreases the production of cytokines that promote inflammation and immune responses against foreign tissues.
Pangraf 0.25 mg Capsule also helps manage autoimmune conditions by modulating immune activity.
The formulation ensures that patients maintain a delicate balance between adequate immunosuppression and minimizing side effects.
Regular monitoring of blood levels is necessary to adjust dosages and ensure efficacy while preventing toxicity.
How to use Pangraf 0.25 mg Capsule
Pangraf 0.25 mg Capsule should be taken exactly as prescribed by a healthcare professional.
The recommended dosage typically starts at one capsule daily, but this may vary based on individual needs.
It is important to take Pangraf 0.25 mg Capsule at the same time each day to maintain consistent blood levels.
The capsule should be swallowed whole with water; do not crush or chew it.
Patients should adhere to their prescribed treatment duration, which may extend for several months or longer post-transplant.
Regular blood tests are essential to monitor drug levels and kidney function during treatment with Pangraf 0.25 mg Capsule.
Consult a healthcare provider before making any changes to dosage or frequency of use.
Special instructions may include avoiding certain foods or medications that could interact with Pangraf 0.25 mg Capsule.
Lifestyle Advice
Maintain a balanced diet rich in fruits and vegetables while taking Pangraf 0.25 mg Capsule to support overall health.
Avoid high-sugar foods that could exacerbate blood glucose levels due to potential side effects from this medication.
Stay hydrated by drinking plenty of water daily; this helps support kidney function during treatment with Pangraf 0.25 mg Capsule.
Engage in regular physical activity as advised by a healthcare provider to enhance overall well-being post-transplant.
Avoid exposure to infections by practicing good hygiene and staying away from sick individuals while on immunosuppressants like Pangraf 0.25 mg Capsule.
Schedule regular follow-up appointments with healthcare providers to monitor health status and medication effectiveness.
Avoid self-medication and consult a healthcare professional before taking any new medications or supplements while using Pangraf 0.25 mg Capsule.
Side Effects
Side Effects
Common side effects of Pangraf 0.25 mg Capsule include increased blood glucose levels and insomnia.
Patients may experience elevated potassium levels and high blood pressure while on this medication.
Gastrointestinal disorders such as nausea or diarrhea can occur with Pangraf 0.25 mg Capsule use.
Some individuals may face renal toxicity or neurotoxicity as potential side effects.
Consult a doctor if side effects persist or worsen over time while taking Pangraf 0.25 mg Capsule.
Serious side effects may include signs of infection, unexplained bruising, or bleeding; seek medical attention immediately if these occur.
Patients should be aware of potential electrolyte imbalances and fluid overload while using this medication.
Precautions and Warnings
Precautions & Warnings
Pangraf 0.25 mg Capsule should not be used by individuals with known hypersensitivity to Tacrolimus or any other components of the formulation.
Patients with liver disease should use Pangraf 0.25 mg Capsule cautiously and under strict medical supervision.
Alcohol consumption should be limited while taking this medication due to potential interactions and increased side effects.
Pregnant or breastfeeding women should consult their healthcare provider before using Pangraf 0.25 mg Capsule.
Driving or operating heavy machinery may be affected by side effects such as dizziness; caution is advised.
Regular monitoring of kidney function is necessary during treatment with Pangraf 0.25 mg Capsule.
Inform healthcare providers about all medications being taken to avoid drug interactions with Pangraf 0.25 mg Capsule.
1. What is Pangraf 0.25 mg Capsule used for?
Pangraf 0.25 mg Capsule is primarily used to prevent organ rejection in transplant patients.
2. How should I take Pangraf 0.25 mg Capsule?
Pangraf 0.25 mg Capsule should be taken as prescribed by your healthcare provider, usually once daily at the same time.
3. What are the common side effects of Pangraf 0.25 mg Capsule?
Common side effects include increased blood glucose levels, insomnia, and gastrointestinal issues.
4. Can I drink alcohol while taking Pangraf 0.25 mg Capsule?
It is advisable to limit alcohol consumption while taking Pangraf 0.25 mg Capsule due to potential interactions.
5. Is there any special monitoring required while on Pangraf 0.25 mg Capsule?
Yes, regular blood tests are necessary to monitor drug levels and kidney function during treatment.
6. Who should avoid using Pangraf 0.25 mg Capsule?
Individuals with known hypersensitivity to Tacrolimus or those with severe liver disease should avoid using this medication.
7. How should I store Pangraf 0.25 mg Capsule?
Store Pangraf 0.25 mg Capsule at room temperature away from moisture and heat.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
SKU
153621
Country of Manufacture
India
Manufacturer Address
Mankind Pharma Ltd
Return/Buy Back policy
Non-returnable
Prescription Required
Yes
Storage
Please refer to the product label for storage information.
Seller
Kogland Commerce Pvt Ltd (TN)
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Related Products
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
